Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function

Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder characterized by prolonged inflammation of the gastrointestinal tract. IBD can result from gut barrier dysfunction, altered gut microbiota, and abnormal intestinal immunity induced by environmental factors in genetically suscepti...

Full description

Bibliographic Details
Main Authors: Mijeong Son, I Seul Park, Soochan Kim, Hyun Woo Ma, Ji Hyung Kim, Tae Il Kim, Won Ho Kim, Jaeyong Han, Seung Won Kim, Jae Hee Cheon
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
Bacteroides vulgatus
inflammatory bowel disease
potassium-competitive acid blocker
proton pump inhibitor
gut barrier function
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.870817/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.870817/full

Similar Items